Shalini Sharp, CFO & Executive Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 9,700 shares at $72.81 ($704K) on 2016-11-09, disclosed to the SEC on 2016-11-10.
Open-market sale of $704k RARE by CFO & Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.68 | 3,895 | $279K | 39.7% |
| 2 | $72.81 | 3,205 | $233K | 33.1% |
| 3 | $73.65 | 2,600 | $191K | 27.2% |
| Total | $72.58 avg | 9,700 | $704K | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |